CIK 0001653087
- Accelerated filer
- Smaller reporting company
Alector, Inc.
Sign in to watch- Ticker
- ALEC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 822933343
- Phone
- +1 415-231-5660
- Business address
- 131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Alector LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $296,087
- in 3 filings
Net −$296,087. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-04 | SCHELLER RICHARD H Director | Sale | −10,000 | $29.67 | $297K | 9,981 |
| 2020-02-04 | Yu Calvin Vice President, Finance | Sale | −63,541 | $30.04 | $1.9M | 125,294 |
| 2020-01-30 | Paul Robert Chief Medical Officer | Sale | −8,000 | $28.00 | $224K | 273,719 |
| 2020-01-27 | Oney Sabah Chief Business Officer | Sale | −14,467 | $25.05 | $362K | 593,918 |
| 2020-01-23 | Oney Sabah Chief Business Officer | Sale | −2,200 | $25.21 | $55K | 593,918 |
| 2020-01-23 | Paul Robert Chief Medical Officer | Sale | −5,401 | $24.22 | $131K | 274,318 |
| 2020-01-23 | Paul Robert Chief Medical Officer | Sale | −599 | $25.22 | $15K | 273,719 |
| 2020-01-22 | King Robert Chief Development Officer | Sale | −3 | $22.01 | $66 | 507,317 |
| 2020-01-21 | King Robert Chief Development Officer | Sale | −14,997 | $22.01 | $330K | 507,320 |
| 2020-01-15 | Paul Robert Chief Medical Officer | Sale | −10,000 | $18.67 | $187K | 273,719 |
| 2020-01-09 | ORBIMED ADVISORS LLC 10% owner | Sale | −286,787 | $19.50 | $5.6M | 7,992,776 |
| 2020-01-09 | ORBIMED ADVISORS LLC 10% owner | Sale | −91,818 | $19.50 | $1.8M | 2,558,963 |
| 2020-01-09 | ORBIMED ADVISORS LLC 10% owner | Sale | −1,392 | $19.50 | $27K | 38,808 |
| 2019-12-26 | ORBIMED ADVISORS LLC 10% owner | Sale | −7,275 | $18.60 | $135K | 8,279,563 |
| 2019-12-26 | ORBIMED ADVISORS LLC 10% owner | Sale | −2,325 | $18.60 | $43K | 2,650,781 |
| 2019-12-26 | ORBIMED ADVISORS LLC 10% owner | Sale | −1,200 | $18.60 | $22K | 40,200 |
| 2019-12-24 | ORBIMED ADVISORS LLC 10% owner | Sale | −48,324 | $19.59 | $947K | 8,286,838 |
| 2019-12-24 | ORBIMED ADVISORS LLC 10% owner | Sale | −15,476 | $19.59 | $303K | 2,653,106 |
| 2019-12-24 | ORBIMED ADVISORS LLC 10% owner | Sale | −8,000 | $19.59 | $157K | 41,400 |
| 2019-12-23 | ORBIMED ADVISORS LLC 10% owner | Sale | −63,535 | $19.82 | $1.3M | 8,335,162 |
Page 11 of 13 · 249 trades